Clinical Trial Update: INEC Study: Immuno-modulating Enteral Nutrition in Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial of immuno-modulating enteral nutrition in cancer has completed, including patients with malnutrition and cancers of the esophagus or head and neck…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Head and Neck Cancer
• Malnutrition

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Malnutrition, Esophageal Cancer | Phase 4 | Status: COMPLETED